Ophthalmology Doctors in Midland, TX Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Dr. Monica Ann De La Paz, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 10100 Loop 40, Midland, TX 79706 Phone: 432-617-0181    Fax: 432-563-0656

Harshad G Shah, MD,PA Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4214 Andrews Hwy, Suite 105, Midland, TX 79703 Phone: 432-686-2020    Fax: 432-570-0888

Robert David Beitman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 805 W Wadley Ave, Midland, TX 79705 Phone: 068-792-5900

Dr. Ronald W Ingram, PA Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2706 W Cuthbert, Ste A, Midland, TX 79701 Phone: 432-694-0999    Fax: 432-694-7414

Dr. Gerardo Escobedo, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10100 Loop 40 West, Midland, TX 79706 Phone: 432-617-0181    Fax: 432-563-0656

Richard B Culbert, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10100 Loop 40 West, Midland, TX 79706 Phone: 432-617-0181    Fax: 432-563-0656

News Archive

Trump administration rule would undo health care protections for LGBTQ patients

A new Trump administration proposal would change the civil rights rules dictating whether providers must care for patients who are transgender or have had an abortion. Supporters of the approach say it protects the freedom of conscience, but opponents say it encourages discrimination.

Prenatal factors may play a role in autism

Mothers of children diagnosed with autism are more likely to be older and to have experienced obstetric difficulties during pregnancy, labor and delivery, but these complications are likely related to underlying genetic factors, according to an article in the June issue of the Archives of General Psychiatry, one of the JAMA/Archives journals.

Wiley-Blackwell signs open access agreements with 3 European research organizations

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, has signed open access funding agreements with three European research organizations: the Max Planck Society in Germany, the FWF Austrian Science Fund, and Telethon, one of the largest biomedical non-profit organizations in Italy.

VIVUS granted three additional patents for Qnexa

VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.

Drug derived from the hydrangea root shows promise for autoimmune disorders

A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI), along with the Harvard School of Dental Medicine.

Read more Medical News

› Verified 4 days ago